HIGHLIGHTS
- who: Xiaolong Wang from the Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, No, Wenhua Xi Road, Jinan, Shandong, China have published the article: CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR, in the Journal: (JOURNAL)
- what: The authors demonstrated that circRNA-CREIT was aberrantly downregulated in doxorubicin resistant triple-negative breast cancer (TNBC) cells and associated with a poor prognosis. The study demonstrated that targeting circRNA-CREIT and SGs could serve as promising therapeutic strategies against TNBC chemoresistance. The study was approved by the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.